BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 26827795)

  • 21. Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer.
    McAnena P; Tanriverdi K; Curran C; Gilligan K; Freedman JE; Brown JAL; Kerin MJ
    BMC Cancer; 2019 May; 19(1):436. PubMed ID: 31077182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysregulation of miR-122, miR-574 and miR-375 in Egyptian patients with breast cancer.
    Elghoroury EA; Abdelghafar EE; Kamel S; Awadallah E; Shalaby A; El-Saeed GSM; Mahmoud E; Kamel MM; Abobakr A; Yousef RN
    PLoS One; 2024; 19(5):e0298536. PubMed ID: 38820252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
    Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ
    Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of microRNAs in Nipple Discharge as Potential Diagnostic Biomarkers for Breast Cancer.
    Zhang K; Zhao S; Wang Q; Yang HS; Zhu J; Ma R
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S536-44. PubMed ID: 25976861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of circulating microRNA signatures for breast cancer detection.
    Chan M; Liaw CS; Ji SM; Tan HH; Wong CY; Thike AA; Tan PH; Ho GH; Lee AS
    Clin Cancer Res; 2013 Aug; 19(16):4477-87. PubMed ID: 23797906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls.
    Hu Z; Dong J; Wang LE; Ma H; Liu J; Zhao Y; Tang J; Chen X; Dai J; Wei Q; Zhang C; Shen H
    Carcinogenesis; 2012 Apr; 33(4):828-34. PubMed ID: 22298638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The expression profiling of serum miR-92a, miR-375, and miR-760 in colorectal cancer: An Egyptian study.
    Elshafei A; Shaker O; Abd El-Motaal O; Salman T
    Tumour Biol; 2017 Jun; 39(6):1010428317705765. PubMed ID: 28618945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
    Wang B; Li J; Sun M; Sun L; Zhang X
    IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating miR-34a and miR-125b as Promising non Invasive Biomarkers in Egyptian Locally Advanced Breast Cancer Patients.
    Kassem NM; Makar WS; Kassem HA; Talima S; Tarek M; Hesham H; El-Desouky MA
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2749-2755. PubMed ID: 31554373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer.
    Jiang X; Du L; Wang L; Li J; Liu Y; Zheng G; Qu A; Zhang X; Pan H; Yang Y; Wang C
    Int J Cancer; 2015 Feb; 136(4):854-62. PubMed ID: 24961907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas.
    Yang C; Wang C; Chen X; Chen S; Zhang Y; Zhi F; Wang J; Li L; Zhou X; Li N; Pan H; Zhang J; Zen K; Zhang CY; Zhang C
    Int J Cancer; 2013 Jan; 132(1):116-27. PubMed ID: 22674182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers.
    van Schooneveld E; Wouters MC; Van der Auwera I; Peeters DJ; Wildiers H; Van Dam PA; Vergote I; Vermeulen PB; Dirix LY; Van Laere SJ
    Breast Cancer Res; 2012 Feb; 14(1):R34. PubMed ID: 22353773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection.
    Schrauder MG; Strick R; Schulz-Wendtland R; Strissel PL; Kahmann L; Loehberg CR; Lux MP; Jud SM; Hartmann A; Hein A; Bayer CM; Bani MR; Richter S; Adamietz BR; Wenkel E; Rauh C; Beckmann MW; Fasching PA
    PLoS One; 2012; 7(1):e29770. PubMed ID: 22242178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer.
    Hua Y; Chen H; Wang L; Wang F; Wang P; Ning Z; Li Y; Liu L; Chen Z; Meng Z
    Cancer Biomark; 2017 Jul; 20(1):95-100. PubMed ID: 28759959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. U6 is not a suitable endogenous control for the quantification of circulating microRNAs.
    Xiang M; Zeng Y; Yang R; Xu H; Chen Z; Zhong J; Xie H; Xu Y; Zeng X
    Biochem Biophys Res Commun; 2014 Nov; 454(1):210-4. PubMed ID: 25450382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast tissue-based microRNA panel highlights microRNA-23a and selected target genes as putative biomarkers for breast cancer.
    Eissa S; Matboli M; Shehata HH
    Transl Res; 2015 Mar; 165(3):417-27. PubMed ID: 25445205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of serum miR-21 in the pathogenesis of familial and triple negative breast cancer.
    Yang L; Feng Y; Qi P; Xu S; Zhou Y
    J Biol Regul Homeost Agents; 2016; 30(4):1041-1045. PubMed ID: 28078851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Specific miRNA Signature in Paired Sera and Tissue Samples of Indian Women with Triple Negative Breast Cancer.
    Thakur S; Grover RK; Gupta S; Yadav AK; Das BC
    PLoS One; 2016; 11(7):e0158946. PubMed ID: 27404381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer.
    Si H; Sun X; Chen Y; Cao Y; Chen S; Wang H; Hu C
    J Cancer Res Clin Oncol; 2013 Feb; 139(2):223-9. PubMed ID: 23052693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum overexpression of microRNA-10b in patients with bone metastatic primary breast cancer.
    Zhao FL; Hu GD; Wang XF; Zhang XH; Zhang YK; Yu ZS
    J Int Med Res; 2012; 40(3):859-66. PubMed ID: 22906258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.